AMPH | Amphastar PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$27.03
-$0.69 (-2.49%)

Amphastar Pharmaceuticals (AMPH) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat above the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits above the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 2 Nov 16:00 ET

Price
above both $27.03 vs 50 $24.87 / 200 $22.25
Projection
No cross projected
Test
No active test
Last cross
Golden cross 2 Oct 2026 ยท projected 25 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $27.72 vs 50 $22.90 / 200 $35.84
Projection
No cross projected
Test
No active test
Last cross
Death cross week of 2 Jun 2025 ยท projected 23 bars out

4-hour as of 3 Nov 16:00 ET

Price
above both $27.12 vs 50 $26.11 / 200 $22.50
Projection
No cross projected
Test
No active test
Last cross
Golden cross 19 Aug 2026 ยท projected 14 bars out

Cross history

40
crosses on record since 2017
20 golden20 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
2 Oct 2026Golden steepdaily25 bars outNot tested
19 Aug 2026Golden4-hour14 bars outNot tested
16 Mar 2026Death steepdaily13 bars outNot tested
9 Mar 2026Death4-hour17 bars outNot tested
13 Jan 2026Golden4-hour18 bars out2 bar cross test

About AMPH

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$10.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.